The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 11, 2016
Filed:
Feb. 04, 2015
Applicant:
Gilead Sciences, Inc., Foster City, CA (US);
Inventors:
Rebecca Restituto Begley, Palo Alto, CA (US);
Joseph Marcello Custodio, San Francisco, CA (US);
Brian P. Kearney, San Francisco, CA (US);
Assignee:
Gilead Sciences, Inc., Foster City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/44 (2006.01); A61K 31/535 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 31/427 (2006.01); A61K 31/438 (2006.01); A61K 31/506 (2006.01); A61K 31/683 (2006.01); A61K 31/675 (2006.01); A61K 31/426 (2006.01); A61K 31/454 (2006.01); A61K 31/473 (2006.01); A61K 31/52 (2006.01); A61K 31/435 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/435 (2013.01); A61K 31/438 (2013.01); A61K 31/454 (2013.01); A61K 31/47 (2013.01); A61K 31/473 (2013.01); A61K 31/506 (2013.01); A61K 31/52 (2013.01); A61K 31/675 (2013.01); A61K 31/683 (2013.01); A61K 45/06 (2013.01);
Abstract
The disclosure describes methods for treatment of patients co-infected with HIV and tuberculosis, wherein the patient receives effective amounts of elvitegravir, an antimycobacterial agent and a CYP inhibitor.